Cold & Cough Remedies (Pharmacies) - United Arab Emirates

Revenue in the Cold & Cough Remedies market is projected to reach US$73.79m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.49%, resulting in a market volume of US$101.10m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$7.69 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in United Arab Emirates is experiencing significant growth, driven by changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in United Arab Emirates are increasingly seeking over-the-counter remedies for cold and cough symptoms. This shift in preference can be attributed to several factors. Firstly, customers are becoming more health-conscious and are actively seeking self-care options for common ailments. Secondly, there is a growing awareness about the effectiveness and safety of over-the-counter remedies, which has led to increased trust and confidence in these products. Finally, the convenience of purchasing cold and cough remedies from pharmacies, which are easily accessible in United Arab Emirates, is also contributing to the shift in customer preferences.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in United Arab Emirates is the increasing demand for natural and herbal remedies. Customers are increasingly opting for products that are perceived to be more natural and have fewer side effects. This trend is driven by the growing awareness about the potential risks associated with the prolonged use of certain active ingredients in traditional cold and cough remedies. As a result, pharmacies in United Arab Emirates are expanding their product offerings to include a wider range of natural and herbal remedies to cater to this demand. Another trend in the market is the rising popularity of combination products. Customers are looking for cold and cough remedies that offer multiple benefits, such as relieving congestion, reducing cough, and soothing sore throat. Combination products that offer these benefits in a single dose are gaining traction in the market. Pharmacies are responding to this trend by stocking a variety of combination products to meet the diverse needs of their customers.

Local special circumstances: United Arab Emirates has a high prevalence of respiratory diseases, which is driving the demand for cold and cough remedies. The country's hot and dry climate, coupled with high levels of air pollution in urban areas, contribute to respiratory issues. As a result, customers in United Arab Emirates are more likely to experience cold and cough symptoms. This local special circumstance creates a favorable market environment for cold and cough remedies, as customers seek relief from their symptoms.

Underlying macroeconomic factors: The strong economic growth and increasing disposable incomes in United Arab Emirates are also contributing to the development of the Cold & Cough Remedies (Pharmacies) market. As people have more disposable income, they are willing to spend on healthcare products, including cold and cough remedies. The government's focus on healthcare and wellness initiatives is also driving the demand for over-the-counter remedies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in United Arab Emirates is growing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. Customers are increasingly seeking over-the-counter remedies, particularly natural and herbal products, and combination remedies. The high prevalence of respiratory diseases in United Arab Emirates, coupled with the country's strong economic growth and increasing disposable incomes, further contribute to the growth of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.